Authors
Latest:
FDA: Simlandi Becomes Third Interchangeable Humira Biosimilar After ApprovalSimlandi is the only biosimilar to Humira on the market that is high-concentration, citrate-free, and interchangeable.
Latest:
Debunking 4 Common Myths About the FluIt’s never too far into flu season to educate patients.
Latest:
Cannabis Consulting: Are You Ready?Most pharmacists are moderately to not-at-all comfortable answering patient questions about cannabis. That needs to change.
Latest:
Communicating with Patients in the Time of COVID-19Pharmacies, just as expected, have showed up in meaningful ways to support their communities.
Latest:
Lumateprone Tosylate Approved for SchizophreniaThe FDA has approved lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) for treatment of schizophrenia in adults.
Latest:
Literature Evaluation: More Than Just the GuidelinesBuilding literature evaluation skills is an essential teaching component during all stages of pharmacy education
Latest:
Entrectinib for ROS1-Positive NSCLC and NTRK-Positive Solid TumorsIn August 2019, the FDA approved entrectinib for treatment of adult patients with metastatic non-small cell lung cancer that is ROS1-positive.
Latest:
Darolutamide for Non-Metastatic Castration-Resistant Prostate CancerIn July 2019, the FDA approved darolutamide (Nubeqa, Bayer) for men with prostate cancer that has not spread (ie, nonmetastatic) and no longer responds to medical or surgical treatment that lowers testosterone (ie androgen deprivation therapy).
Latest:
Fam-trastuzumab Deruxtecan-nxki for HER2-Positive Unresectable or Metastatic Breast CancerFam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo) is indicated for treating adults with unresectable or metastatic HER2-positive breast cancer who have received 2 or more prior anti-HER2–based regimens in the setting of metastasis.
Latest:
Evidence-Based Treatment for Pediatric Migraine PreventionMigraine is one of the most common neurologic disorders in children and adolescents with a prevalence of 7.7%.
Latest:
Evidence-Based Treatment for Pediatric Migraine PreventionMigraine is one of the most common neurologic disorders in children and adolescents with a prevalence of 7.7%.
Latest:
Drug Interaction Concerns for Potential COVID-19 TreatmentsA close look at their potential to interact with other medications is required to limit the risk of adverse outcomes for patients.
Latest:
The Need for Patient-Specific Medication Optimization SystemsMedication decision support tools focused on individual patients can help pharmacists effectively analyze risk of unintended harm, identify and assess potential interventions, and facilitate longitudinal care.
Latest:
Smell Disturbances in the Era of COVID-19Some patients affected by COVID-19 may be concerned about hyposmia (reduced ability to smell) or anosmia (loss of smell) that they experience after contracting the virus.
Latest:
Gut Health Has Impact on the SkinThe gut-brain-skin axis is more important to overall health than previously understood, and prebiotics and probiotics play a large role in the benefits.
Latest:
Vitamin D Maintenance May Benefit Patients With Advanced MelanomaNearly 25% of people “have vitamin D blood levels that are too low or inadequate for bone and overall health,” according to the NIH.
Latest:
Intranasal CGRP Antagonist Is Approved for the Treatment of Acute MigrainesZavegepant joins other CGRP antagonists as an option for individuals experiencing migraine.
Latest:
Thoughts From the Streets: The Rise of Xylazine in Illicit Drug UseRates of xylazine use have skyrocketed in since 2010, leading to an increase in overdoses and death.
Latest:
Medication Dosing in Pediatric Obesity Presents Complexities and ChallengesCareful thought and adjustments are required to avoid exceeding the maximum recommended amount.
Latest:
Review: Vaccine Guidelines for Older AdultsVaccines are important for everyone, but they’re critical for adults older than 65 years.
Latest:
Mind-Body Resilience for Women: A Focus on DepressionDeveloping innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Latest:
Are We Close To A Universal Flu Vaccine?Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.
Latest:
Apetamin Gains Popularity on Social Media as Weight Gain DrugApetamin has been promoted worldwide as a weight gain supplement—but what are the dangers of misuse?
Latest:
Limitations Persist in Growth of Precision MedicineDespite breakthroughs for personalized medicine, barriers still exist in real-world application.
Latest:
Clascoterone Cream 1% for the Treatment of AcneClascoterone cream 1% is a first-in-class topical acne treatment that targets the androgen receptors in the skin.
Latest:
Adverse Effect Burdens of OCS, ICS Use in AsthmaAdverse effects of oral and inhaled corticosteroid use may impact quality of life for people with asthma.
Latest:
Cost Plus Drugs Making Deals with PayersMark Cuban’s Cost Plus Drugs business has entered into agreements with Capital Blue Cross and Rightway.
Latest:
Q&A: Pharmacist Turned Coffee Shop Owner on the Current State of Independent PharmacyChris Schaffner, owner of Schaffner Pharmacy and Apothecary Coffee in Sedro Woolley, Washington, discussed the state of today’s independent pharmacy market, as well as his own pharmacy operations.
Latest:
OTC Medications to Treat the Young AthleteA variety of nonprescription treatments, supplements, and patches can alleviate pain for children and adolescents.
Latest:
How Inappropriate Antibiotic Prescribing Harms PatientsAccording to a study, patients are frequently prescribed broad-spectrum antibiotics instead of narrowly tailored antibiotics, which would be more optimized to treat them.
